Paul Song
Chief Scientific Officer Genequantum Healthcare
Seminars
Tuesday 4th November 2025
Next-Generation Bioconjugate Therapeutics: Driving Innovation With Revolutionary Conjugation Technologies
11:30 am
- Overviewing GeneQuantum’s holistic conjugation and manufacturing platforms: iLDC and iGDC
- Introducing the world’s first rapid ADC screening system: iScreener
- Empowering best-in-class and first-in-class XDC therapeutic development through GeneQuantum’s leading technology platform
